Literature DB >> 10490002

Risk factors for HIV-1 shedding in semen.

C E Speck1, R W Coombs, L A Koutsky, J Zeh, S O Ross, T M Hooton, A C Collier, L Corey, A Cent, J Dragavon, W Lee, E J Johnson, R R Sampoleo, J N Krieger.   

Abstract

Semen is the body fluid most commonly associated with sexual transmission of human immunodeficiency virus type-1 (HIV-1). Because the male genitourinary tract is distinct immunologically from blood, compartment-dependent factors may determine HIV-1 shedding in semen. To identify these factors, the authors obtained 411 semen and blood specimens from 149 men seen up to three times. Seminal plasma was assayed for HIV-1 RNA and semen was cocultured for HIV-1 and cytomegalovirus (CMV), which may up-regulate HIV-1 replication. The best multivariate model for predicting a positive semen HIV-1 coculture included two local urogenital factors, increased seminal polymorphonuclear cell count (odds ratio (OR) = 12.6 for each log10 increase/mL, 95% confidence interval (CI) 12.2, 134.5) and a positive CMV coculture (OR = 3.0, 95% CI 1.2, 7.7). The best multivariate model for predicting semen HIV-1 RNA included two systemic host factors, CD4+ cell counts <200/microliter (OR = 3.0, 95 percent CI 1.3, 6.9) and nucleoside antiretroviral therapy (monotherapy: OR = 0.5, 95% CI 0.3, 1.0; combination therapy: OR = 0.4, 95% CI 0.2, 0.9), and a positive CMV coculture (OR = 1.7, 95% CI 1.0, 3.0). Thus, both systemic and local genitourinary tract factors influence the risk of semen HIV-1 shedding. These findings suggest that measures of systemic virus burden alone may not predict semen infectivity reliably.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490002     DOI: 10.1093/oxfordjournals.aje.a010061

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  21 in total

1.  Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract.

Authors:  Sara Gianella; Sheldon R Morris; Christy Anderson; Celsa A Spina; Milenka V Vargas; Jason A Young; Douglas D Richman; Susan J Little; Davey M Smith
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

Review 2.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

3.  A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.

Authors:  Christophe Vanpouille; Jean A Bernatchez; Andrea Lisco; Anush Arakelyan; Elisa Saba; Matthias Götte; Leonid Margolis
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.177

4.  Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen.

Authors:  L H Ping; M S Cohen; I Hoffman; P Vernazza; F Seillier-Moiseiwitsch; H Chakraborty; P Kazembe; D Zimba; M Maida; S A Fiscus; J J Eron; R Swanstrom; J A Nelson
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection.

Authors:  Pamela P Gumbi; Nonhlanhla N Nkwanyana; Alfred Bere; Wendy A Burgers; Clive M Gray; Anna-Lise Williamson; Margaret Hoffman; David Coetzee; Lynette Denny; Jo-Ann S Passmore
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

6.  HIV type 1 and cytomegalovirus coinfection in the female genital tract.

Authors:  Nell S Lurain; Emmanuel S Robert; Jiahong Xu; Margaret Camarca; Alan Landay; Andrea A Kovacs; Patricia S Reichelderfer
Journal:  J Infect Dis       Date:  2004-06-30       Impact factor: 5.226

7.  Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men.

Authors:  Sara Gianella; Davey M Smith; Milenka V Vargas; Susan J Little; Douglas D Richman; Eric S Daar; Michael P Dube; Fan Zhang; Christina C Ginocchio; Richard H Haubrich; Sheldon R Morris
Journal:  Clin Infect Dis       Date:  2013-04-17       Impact factor: 9.079

8.  Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission.

Authors:  Geoffrey S Gottlieb; Stephen E Hawes; Habibatou D Agne; Joshua E Stern; Cathy W Critchlow; Nancy B Kiviat; Papa Salif Sow
Journal:  AIDS       Date:  2006-04-04       Impact factor: 4.177

9.  Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis.

Authors:  Soren Gantt; Jacquelyn Carlsson; Avinash K Shetty; Kristy D Seidel; Xuan Qin; Junior Mutsvangwa; Georgina Musingwini; Godfrey Woelk; Lynn S Zijenah; David A Katzenstein; Lisa M Frenkel
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

Review 10.  HIV-1 vaginal transmission: cell-free or cell-associated virus?

Authors:  Victor Barreto-de-Souza; Anush Arakelyan; Leonid Margolis; Christophe Vanpouille
Journal:  Am J Reprod Immunol       Date:  2014-04-15       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.